Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Doximity Inc

DOCS

Doximity Inc

Doximity Inc historical holders

total: 4

Durable Capital Partners Doximity Inc transactions over time

Total transactions:
12
New positions:
2
Sold out:
2
Added:
6
Reduced:
2
Held since:
2023 Q4
Held for:
5 quarters
Latest activity:
2025 Q1
Henry Ellenbogen has been an institutional investor in Doximity Inc (DOCS) since 2021 Q2. According to 2026 Q1 report, Henry Ellenbogen doesn't hold any shares. The fund/company first acquired DOCS in 2021 Q2, initially purchasing 750,000 shares. Henry Ellenbogen later completely sold out the position and reinvested in DOCS again in 2023 Q4. Since the initial investment, Durable Capital Partners has made 11 more transactions in this position.

When did Henry Ellenbogen exit their DOCS position?

Henry Ellenbogen no longer holds Doximity Inc (DOCS). They sold off their entire position in 2025 Q1, closing out an investment that began in 2021 Q2.

When did Henry Ellenbogen first invest in DOCS?

Henry Ellenbogen first invested in Doximity Inc (DOCS) in 2021 Q2 at the reported quarter-end price of $58.20 per share, acquiring 750,000 shares in their initial purchase.

What is Henry Ellenbogen's average cost basis for DOCS?

Based on historical transaction data, Henry Ellenbogen's estimated cost basis for Doximity Inc (DOCS) is approximately $30.85 per share. This represents their average reported price* across all buy transactions.

Has Henry Ellenbogen reinvested in DOCS after selling?

Yes, Henry Ellenbogen has shown renewed interest in Doximity Inc (DOCS). After completely selling their position, they reinitiated an investment in 2023 Q4, demonstrating continued conviction in this ticker.

Estimated cost basis*

Weighted AVG buy price:
$30.85
Weighted AVG sell price:
$53.39

DOCS transactions history by Durable Capital Partners

12 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2025 Q1
0.00%
0
$53.39
-100% (-2,889,675)
-1.26%
2024 Q4
1.26%
2,889,675
$53.39
$154,279,748
-63.06% (-4,933,734)
-1.93%
2024 Q3
2.49%
7,823,409
$43.57
$340,865,930
+25.82% (+1,605,342)
+0.51%
2024 Q2
1.43%
6,218,067
$27.97
$173,919,334
+39.59% (+1,763,589)
+0.4%
2024 Q1
0.93%
4,454,478
$26.91
$119,870,003
+124.23% (+2,467,875)
+0.51%
2023 Q4
0.44%
1,986,603
$28.04
$55,704,348
new
+0.44%
2022 Q4
0.00%
0
$30.22
-100% (-78,515)
-0.03%
2022 Q3
0.03%
78,515
$30.22
$2,373,000
-95.61% (-1,711,031)
-0.59%
2022 Q2
0.72%
1,789,546
$34.82
$62,312,000
+8.52% (+140,560)
+0.06%
2022 Q1
0.75%
1,648,986
$52.09
$85,896,000
+54.66% (+582,799)
+0.27%
2021 Q4
0.42%
$50.13
+42.16% (+316,187)
2021 Q2
0.32%
$58.20
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.